These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15052679)

  • 21. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X; Hu J; Zhang X; Fan D
    Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoprotective effects of Helicobacter pylori UreB and HpaA bivalence recombinant vaccine with inner adjuvant on experimental infection in mice].
    Mao YF; Yan J; Xu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 34(5):405-11. PubMed ID: 16216050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Antigenic Evaluation of VacA Antigenic Fragment of Helicobacter Pylori.
    Hasanzadeh L; Ghaznavi-Rad E; Soufian S; Farjadi V; Abtahi H
    Iran J Basic Med Sci; 2013 Jul; 16(7):835-40. PubMed ID: 23997913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of cagA and vacA seropositivity in asymptomatic Bangladeshi children with Helicobacter pylori infection.
    Sarker SA; Nahar S; Rahman M; Bardhan PK; Nair GB; Beglinger C; Gyr N
    Acta Paediatr; 2004 Nov; 93(11):1432-6. PubMed ID: 15513567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
    Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity.
    Sun B; Li ZS; Tu ZX; Xu GM; Du YQ
    World J Gastroenterol; 2006 Nov; 12(43):7042-6. PubMed ID: 17109503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
    Chen XJ; Yan J; Shen YF
    Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Helicobacter pylori AlpA protein and its immunogenicity.
    Xue J; Bai Y; Chen Y; Wang JD; Zhang ZS; Zhang YL; Zhou DY
    World J Gastroenterol; 2005 Apr; 11(15):2260-3. PubMed ID: 15818736
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Link A; Langner C; Schirrmeister W; Habendorf W; Weigt J; Venerito M; Tammer I; Schlüter D; Schlaermann P; Meyer TF; Wex T; Malfertheiner P
    World J Gastroenterol; 2017 Jul; 23(26):4712-4723. PubMed ID: 28765692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and immunogenicity analysis of a recombinant fusion protein of V. Cholera ctB and H. pylori ure I].
    Wang BN; Yang XF; Shi QF; Li MY; Chen CP; Cao K; Li H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):276-9. PubMed ID: 16643777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of serum antibody titers to Helicobacter pylori lipopolysaccharides, CagA, VacA and partially purified cellular extracts in a Japanese population.
    Yokota S; Amano K; Fujii N; Yokochi T
    FEMS Microbiol Lett; 2000 Apr; 185(2):193-8. PubMed ID: 10754247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Production of recombinant fragment of VacA protein and development of non-invasive method for the diagnosis of Helicobacter pylori infection].
    Belyĭ IuF; Sheklakova LA; Vakhrameeva MS; Zhukhovitskiĭ VG; Petrukhin VG; Belaia IuA
    Mol Gen Mikrobiol Virusol; 2005; (1):32-5. PubMed ID: 15790031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors.
    Eskandari-Nasab E; Sepanjnia A; Moghadampour M; Hadadi-Fishani M; Rezaeifar A; Asadi-Saghandi A; Sadeghi-Kalani B; Manshadi MD; Pourrajab F; Pourmasoumi H
    Scand J Infect Dis; 2013 May; 45(5):342-9. PubMed ID: 23163894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori multiplex serology.
    Michel A; Waterboer T; Kist M; Pawlita M
    Helicobacter; 2009 Dec; 14(6):525-35. PubMed ID: 19889070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study.
    Malfertheiner P; Selgrad M; Wex T; Romi B; Borgogni E; Spensieri F; Zedda L; Ruggiero P; Pancotto L; Censini S; Palla E; Kanesa-Thasan N; Scharschmidt B; Rappuoli R; Graham DY; Schiavetti F; Del Giudice G
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):698-707. PubMed ID: 30042064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
    Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
    Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.
    Figueiredo C; Quint W; Nouhan N; van den Munckhof H; Herbrink P; Scherpenisse J; de Boer W; Schneeberger P; Perez-Perez G; Blaser MJ; van Doorn LJ
    J Clin Microbiol; 2001 Apr; 39(4):1339-44. PubMed ID: 11283053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice.
    Hong KS; Ki MR; Ullah HMA; Lee EJ; Kim YD; Chung MJ; Elfadl AK; Park JK; Jeong KS
    Vaccine; 2018 Jan; 36(3):371-380. PubMed ID: 29223485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.